Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

News
flag_-_union_flag

New web portal highlights UK strengths in medicines manufacturing

December 1, 2015
Manufacturing and Production ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production

A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines …

News
nhsa

North of England secures new ‘centres of excellence’ in ‘precision medicine’

October 27, 2015
Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK

The umbrella group formed by the leading northern universities, teaching hospitals and Academic Health Science Networks – the Northern Health …

News
healthcare tech

Doctors ‘distrust apps developed by pharma’ – survey

July 31, 2015
Medical Communications France, GPs, Germany, Healthcare Technologies, UK, chronic disease, disease management, healthcare tech

A study of GPs in three European countries show GPs feel there is a role for healthcare technologies in disease …

News
Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

July 14, 2015
Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …

News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

News

Prices to be printed on all prescribed NHS drugs over £20

July 2, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines

NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …

News
Lilly image

UK Court weighs in on Lilly-Actavis Alimta case

June 26, 2015
Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly

Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …

News

NICE reworks cancer guidance for GPs

June 23, 2015
Sales and Marketing Cancer, GPs, NICE, UK, baker, research

The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

News
Zydelig image

NICE wants more answers from Gilead on Zydelig

June 18, 2015
Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance.  But the …

News
NHS image

Cameron restates £8 billion NHS funding plans

May 18, 2015
Sales and Marketing BMA, Cameron, NHS, UK

UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …

News

Pharma accused of hiding behind regulation and undermining NICE

April 29, 2015
Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma

University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …

News

Cancer Research Technology and Medivir to develop new class of cancer drugs

April 13, 2015
Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology

Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …

News
Market access means new drugs are available to prescribe to patients

Refining UK market access

April 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access

“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …

Feature
Genome image

Big pharma teams with government on genomic research

March 27, 2015
Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes

Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026